Efficacy and Safety of an Anti-nerve Growth Factor Antibody (Frunevetmab) for the Treatment of Degenerative Joint Disease-Associated Chronic Pain in Cats: A Multisite Pilot Field Study

Background: Pain management for cats with degenerative joint disease (DJD) remains a critical unmet need. Recent work has shown promise for a feline-specific anti-nerve growth factor monoclonal antibody (frunevetmab) to deliver safe and effective pain management. Our objectives were to evaluate the...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Vet Sci
Huvudupphovsmän: Gruen, Margaret E., Myers, Jamie A. E., Lascelles, B. Duncan X.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2021
Ämnen:
Veterinary Science
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8195238/
https://ncbi.nlm.nih.gov/pubmed/34124212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fvets.2021.610028
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk